
ROVI · Laboratorios Farmaceuticos Rovi, S.A.
58.15
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro3.02B
PE
23.10
EV/EBITDA
16.2
DIV Yield
1.2%
Payout Ratio
28%
MQV Rating
4Weak
As at 08/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Consensus Cheap
- HALO 100
- HALO 200
- HALO 50
- HALO All
- HALO Balance Sheet
- Hammer Bullish (Realtime)
Key Fundamentals
EPS 3 yr Growth
-26.50%
EBITDA Margin
27.40%
Operating Cashflow
€185m
Free Cash Flow Return
26.10%
ROIC
19.80%
Interest Coverage
71.50
Quick Ratio
1.60
Performance
52 weeks range
Low 53.1 - 86.7
Trade Value (12mth)
US$2,330,022.00
1 week
0.34%
1 month
2.25%
YTD
-6.87%
1 year
0.94%
All time high
94.80
Additional Data
Shares Outstanding (Fully Diluted)
51m
HALO Sector
Healthcare
Next Company Report Date
24-Feb-27
Next Ex Dividend Date
13-Jul-26
Next Dividend Pay Date
15-Jul-26
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Neutral
Earnings
Weak
Growth
Earnings
Very Weak
Dividends
Strong
Quality
Capital Efficiency
Strong
Balance Sheet
Very Strong
Valuation
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Norbel Inversiones SL | Private Company |
| Indumenta Pueri SL | Private Company |
| Laboratorios Farmaceúticos Rovi SA | Public Company |